Thomas, Angeline
Dobbels, Els F. M.
Springer, Priscilla E.
Ackermann, Christelle
Cotton, Mark F.
Laughton, Barbara
Funding for this research was provided by:
National Institutes of Health (U19 A153217, HHSN272200800014c)
Eunice Kennedy Shriver National Institute of Child Health and Human Development (R01 HD071664)
Harry Crossley Foundation
South African Medical Research Foundation
National Research Foundation of South Africa
GlaxoSmithKline
Viiv Healthcare
Article History
Received: 10 August 2017
Accepted: 25 January 2018
First Online: 9 February 2018
Compliance with ethical standards
:
: The authors declare that they have no conflict of interest.
: The above child was enrolled on the neurodevelopmental sub-study of the CHER trial. The sub-study approved by the Stellenbosch University health research ethics committee (reg no N05/05/092 and M11/10/042) and was been performed in accordance with the ethical standards as laid down in the 1964 Declaration of Helsinki and its later amendments or comparable ethical standards. Consent to participate was obtained in person from the child’s mother in her home language. At 9 the child provided assent.